(Q34151732)

English

Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

James L. Gulley

2

object named as

James L Gulley

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

10

object named as

Susan E Bates

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

11

object named as

Tito Fojo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

William Douglas Figg, Sr.

6

object named as

William D Figg

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

5

object named as

William Dahut

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Wilfred D Stein

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jeff Schlom

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ravi A Madan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yang-Min Ning

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Phil M Arlen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Doug Price

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

0 references

publication date

24 November 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Clinical Cancer Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

907-917

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of patients with rising prostate-specific antigen after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DYNAMICS OF TUMOR GROWTH

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines: the role of tumor burden in tipping the scale toward vaccine efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options in androgen-independent prostate cancer: building on docetaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing efficacy of therapeutic vaccinations by combination with other modalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines: moving beyond current paradigms

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical safety of a viral vector based prostate cancer vaccine strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is cell death a critical end point for anticancer therapies or is cytostasis sufficient?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial data

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/21106727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-10-1762

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

release_mlpticbesrajnjftlviyb3jwne

1 reference

https://api.fatcat.wiki/v0/release/mlpticbesrajnjftlviyb3jwne

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106727%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34151732&oldid=1836913443"